Inactive

10/22/2024: Final solicitation posted Amendment 1 to Draft Solicitation (10/11/2024): The purpose of this amendment is to update the Proposal Due Date to November 18, 2024 at 12pm EST. The anticipated... 10/22/2024: Final solicitation posted Amendment 1 to Draft Solicitation (10/11/2024): The purpose of this amendment is to update the Proposal Due Date to November 18, 2024 at 12pm EST. The anticipated solicitation release date was also updated to October 22, 2024. Overview: ARPA-H is launching an Exploration Topic that aims to enable pediatric patients with rare genetic diseases to access clinically validated curative cell therapies by advancing novel quality assurance mechanisms at Academic Medical Centers (AMC). This ET expands the Resilient System Office’s (RSO) funding approach associated with the interest areas included within Appendix A to the Master Announcement Instructions, ARPA-H-MAI-24-01.